Ostalo
TREATMENT OF ANEMIA IN CHRONIC KIDNEY DISEASE – POSITION STATEMENT OF THE CROATIAN SOCIETY FOR NEPHROLOGY, DIALYSIS AND TRANSPLANTATION AND REVIEW OF THE KDIGO AND ERPB GUIDELINES
SANJIN RAČKI
orcid.org/0000-0002-3736-0929
; Klinički bolnički centar Rijeka, Zavod za nefrologiju i dijalizu, Rijeka, Hrvatska
NIKOLINA BAŠIĆ-JUKIĆ
; Klinički bolnički centar Zagreb, Zavod za nefrologiju, arterijsku hipertenziju, dijalizu i transplantaciju, Zagreb, Hrvatska
PETAR KES
; Klinički bolnički centar Zagreb, Zavod za nefrologiju, arterijsku hipertenziju, dijalizu i transplantaciju, Zagreb, Hrvatska
DRAGAN LJUTIĆ
; Klinički bolnički centar Split, Zavod za nefrologiju i dijalizu, Split, Hrvatska
VESNA LOVČIĆ
; Opća bolnica Bjelovar, Bjelovar, Krvatska
INGRID PRKAČIN
; Klinička bolnica Merkur, Zavod za nefrologiju i dijalizu, Zagreb, Hrvatska
JOSIPA RADIĆ
; Klinički bolnički centar Split, Zavod za nefrologiju i dijalizu, Split, Hrvatska
BOŽIDAR VUJIČIĆ
; Klinički bolnički centar Rijeka, Zavod za nefrologiju i dijalizu, Rijeka, Hrvatska
IVAN BUBIĆ
; Klinički bolnički centar Rijeka, Zavod za nefrologiju i dijalizu, Rijeka, Hrvatska
MARKO JAKIĆ
; Klinički bolnički centar Osijek, Zavod za nefrologiju i dijalizu, Osijek, Hrvatska
ŽARKO BELAVIĆ
; Fresenius Medical Care
SINIŠA ŠEFER
; Klinički bolnički centar "Sestre milosrdnice”, Zavod za nefrologiju i dijalizu, Zagreb, Hrvatska
MARIO PEHAR
; Klinička bolnica Dubrava, Zavod za nefrologiju i dijalizu, Zagreb, Hrvatska
DRAGAN KLARIĆ
; Opća bolnica Zadar, Zadar, Hrvatska
MARIJANA GULIN
; Opća bolnica Šibenik, Šibenik, Hrvatska
Sažetak
Renal anemia is the result of chronic kidney disease (CKD) and deteriorates with disease progression. Anemia may be the first sign of kidney disease. In all patients with anemia and CKD, diagnostic evaluation is required. Prior to diagnosing renal anemia, it is necessary to eliminate the other possible causes. Direct correlation between the concentration of hemoglobin and the stage of renal failure is well known. Early development of anemia is common in diabetic patients. Correction of anemia may slow the progression of CKD. Anemia is an independent risk factor for developing cardiovascular disease in patients with CKD. Treatment of anemia in patients with CKD is based on current guidelines. Recently, the Kidney Disease: Improving Global Outcomes (KDIGO) group has produced comprehensive clinical practice guidelines for the management of anemia in CKD patients and ERBP (European Renal Best Practice) group its position statement and comments on the KDIGO guidelines. The Croatian Society of Nephrology, Dialysis and Transplantation (HDNDT) has already published its own guidelines based on the recommendations and positive experience of European and international professional societies, as well as on own experience. The latest version of Croatian guidelines was published in 2008. Since then, on the basis of research and clinical practice, there have been numerous changes in the modern understanding of the treatment of anemia in CKD. Consequently, HDNDT hereby publishes a review of the recent recommendations of international professional societies, expressing the attitude about treating anemia in CKD as a basis for new guidelines tailored to the present time.
Ključne riječi
anemia; chronic kidney disease; erythropoiesis stimulating agents; iron; mortality
Hrčak ID:
126932
URI
Datum izdavanja:
14.9.2014.
Posjeta: 3.408 *